(Q42702371)

English

Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study

scientific article published on 3 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John J. P. Kastelein

1

object named as

John J P Kastelein

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Joost Besseling

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sukrut Shah

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Jean Bergeron

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Gisle Langslet

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

G Kees Hovingh

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Naab Al-Saady

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Michiel Koeijvoets

8

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

John Hunter

9

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Amy O Johnson-Levonas

10

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Jennifer Fable

11

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Aditi Sapre

12

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Yale Mitchel

13

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

language of work or name

0 references

publication date

3 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

385

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

9983

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

2153-2161

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Diagnosis and treatment of familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of mipomersen sodium (Kynamro).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of anacetrapib in patients with or at high risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of extended-release niacin with laropiprant in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lapaquistat Acetate: Development of a Squalene Synthase Inhibitor for the Treatment of Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesteryl ester transfer protein, high density lipoprotein and arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin with or without ezetimibe in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 In

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised con

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962115-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)62115-2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42702371&oldid=2042031731"